Book cover for Biotech Hedge Funds by Basil Hantash and Robert Fleming
2011 Released
88 Pages
1-2 Hours
Ebook Unavailable
Audiobook Unavailable
Hardback Unavailable
VDM Verlag ISBN 9783639304879

The initial goal established at the commencement of the research was to build a novel hedge fund investment thesis that exploited information asymmetries over short-term windows. This study commenced in mid-2009, at the early stages of the recovery of the US economy (which is debatable) following the 2007-2008 financial and economic crises. We were presented a unique opportunity to explore the successes and failings of hedge funds in general through the years immediately preceding the crisis. We were hoping to uncover sector-specific investment theses which demonstrated a strong competency in hedging during the recent economic shock and to determine whether robust hedging always comes at the cost of upside participation. Further, we hoped to identify investment theses that thrived by employing speculative directional trading strategies and to explore their exposures/risks? Our research establishes a solid framework for analysis of biotech hedge funds and revealed clear possibilities for creating trading systems with an edge.

Robert Fleming

Robert Fleming, a former award-winning New York Daily News reporter, novelist, and editor, is a native of Cleveland, Ohio. A graduate of Columbia University’s School of Journalism, he has published several books including The Wisdom of Elders, The African American Writer’s Handbook, Rescuing A Neighborhood, The Success of Caroline Jones Advertising Inc., Alvin Ailey, Havoc After Dark, and Fever in the Blood. He also edited the anthologies After Hours and Intimacy.

More by Robert Fleming

Why Readwise Books?

Readwise Books is an ebook & audiobook platform that automatically logs how much you and your friends read, making it fun and easy to read more. Learn more →